Mortality rate for all eIND patients (excluding terminal Montefiore patients) whose outcomes have been reported is 15%.

Surgeon I speak to regularly sees 30% mortality for this demographic at her hospital.

I'm not expecting trial patients in treatmeant arm to perform worse than 15%.